Patent · US Active

GPR 17 agonists and screening assay

US8623593B1 · kind B1 · utility

0Cited by

2References

1Claims

0Family size

Assignee

Rheinische Friedrich-Wilhems-Universitaet Bonn · DE

Inventors

Evi Kostenis · Bonn, DE
Andreas Spinrath · Munich, DE
Stephanie Hennen · Aachen, DE
Lucas Peters · Palmdale, US
Christa E. Müller · Bonn, DE
Rhalid Akkari · Pantin, FR
Younis Baqi · Bonn, DE
Kirsten Ritter · Jena, DE

Key dates

Filing date	Mar 4, 2013
Grant date	Jan 7, 2014
Priority date	—
Expiry date	Mar 4, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/2871
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention is related to a method of determining a test compound's ability to modify the biological activity of a GPR17. Said method comprises, among others, the step of contacting the test compound with a GPR17, or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.